Abstract 2274: An immune-educating therapy, Maveropepimut-S, elicits a diverse and active anti-tumor T cell response in patients with advanced recurrent ovarian cancer

Authors: Kelcey Patterson, Barry Kennedy, Walead Ebrahimizadeh, Aurelio Lobo, Heather Hirsch, Heather Torrey, Valarmathy Kaliaperumal, Lisa MacDonald, Jeremy Graff, Stephan Fiset, Olga Hrytsenko

Published: 2023-04-04

DOI: 10.1158/1538-7445.am2023-2274

Source: Full article